Exact Sciences Corporation (EXAS)

Bamco Inc. NY grew its holdings in Exact Sciences Corporation (NASDAQ: EXAS) by 26.4% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional i...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect® ...

First Trust Advisors LP cut its position in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 2.5% in the second quarter, according to the company in its most recent filing with the Securities an...

Baird Financial Group Inc. reduced its holdings in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 9.7% during the second quarter, according to its most recent Form 13F filing with the Securiti...

Fisher Asset Management LLC trimmed its position in Exact Sciences Corporation (NASDAQ: EXAS) by 15.0% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 1...

Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock?...

As of Dec. 2, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions....

Advisors Asset Management Inc. reduced its stake in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 31.4% during the undefined quarter, according to its most recent 13F filing with the SEC. The...

Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact Sciences' key products and fuel its innovative engin...

Exact Sciences Corporation (NASDAQ: EXAS - Get Free Report) has been given an average recommendation of "Hold" by the twenty-six research firms that are covering the stock, MarketBeat reports. One inv...